Form 4: Century Therapeutics Officer Sells Shares to Cover Tax Obligations

Adrienne Farid, Chief Operations Officer of Century Therapeutics, sold 1,024 shares of common stock on May 5, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 5, 2025, Adrienne Farid, the Chief Operations Officer of Century Therapeutics, sold 1,024 shares of the company's common stock.
• The sale was executed at a price of $0.55 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Farid directly owns 250,693 shares of Century Therapeutics.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Future Outlook

There are no forward-looking statements in this document.

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

Form 4 filings are a routine part of insider trading activity and are required by the SEC to ensure transparency in the market. This transaction appears to be a standard sale to cover tax obligations, which is a common practice among corporate executives.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Century Therapeutics, Adrienne Farid, IPSC, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Chief Operations Officer